Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by the loss of cortical and spinal motor neurons. The second most common cause of familial ALS (fALS) is mutation of Cu/Zn superoxide dismutase 1 (SOD1). These mutations likely confer - as yet unidentified, toxic properties. Consistent with this idea, fALS-SOD1 overexpression recapitulates some end-stage aspects of disease, including dramatic SOD1 aggregation, neuronal dysfunction and death. However, overexpression models may obscure early-stage defects and the potential impacts of diminished fALS-SOD1 activity. Indeed, reminiscent of SOD1 null mice, a precise fALS-SOD1 knock-in mouse model results in peripheral neuropathy (PMID:25468678).To investigate whether SOD1 loss of function contributes to disease and early-stage events, we generated single-copy fALS SOD-1 models in C. elegans. We inserted conserved patient alleles H71Y and G85R into the C. elegans
sod-1 gene. fALS
sod-1 alleles increased aggregation of human wild-type SOD1-YFP in motor neurons. Both
sod-1 loss and fALS
sod-1 mutations led to decreased lifespan and hypersensitivity to oxidative stress. Interestingly, both
sod-1 null animals and fALS
sod-1 animals were hypersensitive to the cholinesterase inhibitor aldicarb. Examination of the fluorescently labeled pre-synaptic proteins in cholinergic motor neurons revealed perturbations in the synaptic transmission machinery of
sod-1 loss of function animals. Oxidative stress was sufficient to increase aggregation of human wild-type SOD1-YFP and exacerbated aldicarb hypersensitivity. Intriguingly, stress also induced neurodegeneration of glutamatergic neurons and cholinergic motor neurons in both fALS
sod-1 and
sod-1 loss of function animals. Our results suggest that exposure to exogenous stress may unmask or aggravate defects observed in fALS
sod-1 animals.In summary, we have generated a non-overexpression fALS SOD1 model in C. elegans that may reflect early stage events in ALS pathogenesis. These animals greatly differ from those over-expressing human fALS SOD1 (PMID:19165329). Analysis of
sod-1 loss of function and fALS
sod-1 animals suggests that loss of SOD-1 function impairs neuromuscular junction activity, impairs stress resistance, and contributes to neurodegeneration.